Reduce neuroinflammation, a key driver of brain aging
The primary endpoint was major adverse cardiovascular events (often called MACE), a combined measure of: Cardiovascular death Nonfatal heart attack Nonfatal stroke Over a median follow-up of about 3.5 years, semaglutide reduced the relative risk of these events by about 20% compared with placebo
When handled correctly, LiPo batteries are perfectly safe
Mounjaro (tirzepatide) is a self-injectable treatment used for weight loss and type 2 diabetes, helping control blood sugar and reduce appetite
GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes
Glapp supports all major GLP-1 medications